MECHANISMS OF NITRATE TOLERANCE - A REVIEW

被引：17

作者：

KATZ, RJ

机构：

[1] Division of Cardiology, George Washington University Medical Center, Washington, D. C., 20037

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷 / 01期

关键词：

drug tolerance; glyceryl trinitrate; isosorhide dinitrate; N-acetylcysteine; nitroglycerin; sulfhydryl; vasodilators;

D O I：

10.1007/BF01857640

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

With the increased use of long-acting nitroglycerin preparations, there has been greater recognition of the problem of nitrate tolerance. In recent years extensive research has broadened our understanding of the mechanisms of nitroglycerin action and the mechanisms of drug attenuation. This paper reviews the current state of knowledge regarding nitroglycerin tolerance, with an emphasis on the concepts of cellular and neurohumoral mechanisms of drug attenuation. The discussion includes potential approaches to prevent nitrate tolerance, including the introduction of a nitrate-free interval, or concomitant administration of sulfhydryl donors or neurohumoral blocking agents. © 1990 Kluwer Academic Publishers.

引用

页码：247 / 252

页数：6

共 55 条

[41]

Levy W., Katz R.J., Wasserman A.G., Methionine reverses tolerance to transdermal nitroglycerin (abstract), J Am Coll Cardiol, 13, (1989)

[42]

Munzel T., Holtz J., Mulsch A., Et al., Nitrate tolerance in epicardial arteries or in the venous system is not reversed by n-acetylcysteine in vivo, but tolerance-independent interactions exist, Circulation, 79, pp. 188-197, (1989)

[43]

Colucci W.S., Willia G.H., Alexander R.W., Et al., Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure, Am J Med, 71, pp. 89-99, (1981)

[44]

Brunton T.L., On the use of nitrate of amyl in angina pectoris, Lancet, 2, pp. 97-98, (1867)

[45]

Lis Y., Bennett K., Lambert G., Robson D., A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction, Intensive Care Med, 10, pp. 179-184, (1984)

[46]

Bennett D., Barclay S.A., Ada J., Et al., Transdermal nitroglycerin causes plasma volume expansion which may explain tolerance to transdermal nitroglycerin (abstract), Eur Heart J, 8, (1987)

[47]

Packer M., Meller J., Medina N., Et al., Rebound hemodynamic events after abrupt withdrawal of nitroprusside in patients with severe chronic heart failure, N Engl J Med, 301, pp. 1193-1197, (1979)

[48]

Olivari M.T., Carlyle P.F., Levine T.B., Et al., Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure, J Am Coll Cardiol, 2, pp. 872-878, (1983)

[49]

Packer M., Kessler P.D., Gottlieb S., Et al., Does neurohumoral activation contribute to the development of nitrate tolerance in patients with chronic heart failure (abstract)?, Circulation, 78, (1988)

[50]

Agabiti-Rosei E., Muiesan M.L., Beschi M., Et al., Antianginal efficacy of transdermal nitroglycerin as related to adrenergic and renin-aldosterone systems (abstract), Circulation, 76, (1987)

← 1 2 3 4 5 6 →